The gradual decrease in susceptibility of the gonococcus to penicillin has led authorities to recommend ever larger doses for the therapy of gonorrhoea. The current recommendation of the U.S. Public Health Service for the treatment of infections in women is the administration of 4-8 m.u. aqueous procaine penicillin; one half that amount is advised for cases in men.
In seeking alternative antibiotics for the treatment of gonorrhoea, we have recently completed a trial of minocycline (7 dimethylamino-6-deoxy-6-dimethyltetracycine), a new semisynthetic derivative of tetracycline. The preparation and some biological properties of minocycline were described by Martell and Boothe (1967) .
Subsequent investigations (Fedorko, Katz, and Allnoch, 1968; Frisk and Tunevall, 1969;  Washington, Yu, and Martin, 1970) have shown minocycline to have a broad spectrum much like tetracycline, with apparently more activity against the staphylococcus than tetracycline. Martin, Lester, Kellogg, and Thayer (1969) found that gonococcal strains isolated from patients after failure of treatment with penicillin were inhibited in vitro by minocycline at lower concentrations than was the case with tetracycline or doxycycline. The minimum inhibitory concentration (MIC) of minocycline ranged from 0125 to 1 0 ,Lg./ml. (mean 0 52); for tetracycline the MIC ranged from 0-125-20 ,±g./ml. (mean 075). Steigbigel, Reed, and Finland (1968a) Defaulters constitute a significant problem in evaluating the effectiveness of therapy in acute gonorrhoea. Some workers (Tiedemann, Hackney, Simpson, and Price, 1962; Lentz, MacVicar, and Beilstein, 1962) 
